Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ming-Hsi Wang, K. Helzlsouer, Michael Smith, J. Hoffman-Bolton, Sandra Clipp, Viktoriya Grinberg, A. Marzo, W. Isaacs, C. Drake, Y. Shugart, E. Platz (2009)Association of IL10 and Other immune response‐ and obesity‐related genes with prostate cancer in CLUE II
The Prostate, 69
C. Edwards‐Smith, J. Jonsson, D. Purdie, A. Bansal, Claudia Shorthouse, E. Powell (1999)Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
U. Langsenlehner, P. Krippl, W. Renner, B. Yazdani-Biuki, T. Eder, H. Köppel, T. Wascher, B. Paulweber, H. Samonigg (2005)Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
Breast Cancer Research and Treatment, 90
H. Shin, B. Park, L. Kim, J. Jung, Jun Kim, Jung‐Hwan Yoon, Y. Kim, Hyo‐suk Lee (2003)Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma.
Human molecular genetics, 12 8
E. Alamartine, P. Berthoux, C. Mariat, F. Cambazard, F. Berthoux (2003)Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation.
The Journal of investigative dermatology, 120 1
T. Eder, R. Mayer, U. Langsenlehner, W. Renner, P. Krippl, T. Wascher, K. Pummer, K. Kapp (2007)Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
European journal of cancer, 43 3
D. Budiani, S. Hutahaean, S. Haryana, M. Soesatyo, W. Sosroseno (2002)Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 35 4
L. Kozłowski, I. Zakrzewska, P. Tokajuk, M. Wojtukiewicz (2003)Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
Roczniki Akademii Medycznej w Bialymstoku, 48
Fanjun Kong, Jie Liu, Yongheng Liu, B. Song, Hualing Wang, Wen-Chao Liu (2010)Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population
Journal of Experimental & Clinical Cancer Research : CR, 29
E. Lech-Maranda, J. Bienvenu, A. Michallet, R. Houot, T. Robak, B. Coiffier, G. Salles (2006)Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.
European cytokine network, 17 1
Ming-Shiang Wu, Chun-Ying Wu, Chien-Jen Chen, Ming-Tsan Lin, C. Shun, Jaw-Town Lin (2003)Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese
International Journal of Cancer, 104
J. Higgins, S. Thompson (2002)Quantifying heterogeneity in a meta‐analysis
Statistics in Medicine, 21
A. Neuner, M. Schindel, U. Wildenberg, T. Muley, H. Lahm, J. Fischer (2002)Prognostic significance of cytokine modulation in non‐small cell lung cancer
International Journal of Cancer, 101
R. Dersimonian, R. Dersimonian, N. Laird, N. Laird (1986)Meta-analysis in clinical trials.
Controlled clinical trials, 7 3
T. Pogoda, O. Marsheva, P. Kostin, V. Maksimov, I. Kulikov, T. Openko, G. Simonova, M. Voyevoda, E. Generozov, V. Govorun (2007)Association of haplotypes of interleukin-10 gene with the risk of cancer
Bulletin of Experimental Biology and Medicine, 144
S. Mccarron, S. Edwards, P. Evans, R. Gibbs, D. Dearnaley, A. Dowe, C. Southgate, D. Easton, R. Eeles, W. Howell (2002)Influence of cytokine gene polymorphisms on the development of prostate cancer.
Cancer research, 62 12
C. Begg, Madhuchhanda Mazumdar (1994)Operating characteristics of a rank correlation test for publication bias.
Biometrics, 50 4
S. Hoffmann, E. Stanley, E. Cox, N. Craighead, B. Dimercurio, D. Koziol, D. Harlan, A. Kirk, P. Blair (2001)ASSOCIATION OF CYTOKINE POLYMORPHIC INHERITANCE AND IN VITRO CYTOKINE PRODUCTION IN ANTI-CD3/CD28-STIMULATED PERIPHERAL BLOOD LYMPHOCYTES1
J. Martínez-Escribano, M. Moya-Quiles, M. Muro, O. Montes-Ares, T. Hernández-Caselles, J. Frías, M. Álvarez-López (2002)Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients.
Melanoma research, 12 5
M. Sugimoto, T. Furuta, N. Shirai, A. Nakamura, M. Kajimura, H. Sugimura, A. Hishida (2007)Effects of interleukin‐10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects
Journal of Gastroenterology and Hepatology, 22
F Kong, J Liu, Y Liu, B Song, H Wang, W Liu (2010)Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population
J Exp Clin Cancer Res CR, 29
J Eskdale, G Gallagher, CL Verweij, V Keijsers, RG Westendorp, TW Huizinga (1998)Interleukin 10 secretion in relation to human IL-10 locus haplotypes
Proc Natl Acad Sci USA, 95
M. Matsuda, F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Qian Zhang, M. Masucci, R. Kiessling (1994)Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression
The Journal of Experimental Medicine, 180
A Patio-Garcia, E Sotillo-Pieiro, C Modesto, L Sierrases-Maga (2000)Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer
J Med Genet, 37
C. Mok, J. Lanchbury, D. Chan, Chak Lau (1998)Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus.
Arthritis and rheumatism, 41 6
The IL-10 promoter haplotype and cancer risk 319
Alexander Liede, Tuya Pal, M. Mitchell, S. Narod (2000)Hemiplegic cerebral palsy and the factor V Leiden mutation
Journal of Medical Genetics, 37
Pravin Kesarwani, D. Ahirwar, A. Mandhani, A. Singh, D. Dalela, A. Srivastava, R. Mittal (2009)IL-10 −1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort
World Journal of Urology, 27
J. Eskdale, G. Gallagher, C. Verweij, V. Keijsers, R. Westendorp, T. Huizinga (1998)Interleukin 10 secretion in relation to human IL-10 locus haplotypes.
Proceedings of the National Academy of Sciences of the United States of America, 95 16
Jie Liu, B. Song, X. Bai, Wenjian Liu, Zeng-jun Li, Jialin Wang, Yan Zheng, Zhehai Wang (2010)Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese
BMC Cancer, 10
N Mantel, W Haenszel (1959)Statistical aspects of the analysis of data from retrospective studies of disease
J Natl Cancer Inst, 22
T. Nagano, M. Kunisada, Xijun Yu, T. Masaki, C. Nishigori (2007)Involvement of Interleukin‐10 Promoter Polymorphisms in Nonmelanoma Skin Cancers—A Case Study in Non‐Caucasian Skin Cancer Patients †
Photochemistry and Photobiology, 84
A. Jebreel, D. Mistry, D. Loke, G. Dunn, V. Hough, K. Oliver, N. Stafford, J. Greenman (2007)Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
The Journal of laryngology and otology, 121 3
Kwang-Pil Ko, Sue-Kyung Park, Lisa Cho, J. Gwack, Jae-Jeong Yang, A. Shin, Cheong-sik Kim, Yeonju Kim, D. Kang, Soung‐Hoon Chang, Hai-rim Shin, K. Yoo (2009)Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk.
The Journal of nutrition, 139 5
D. Michaud, S. Daugherty, S. Daugherty, Sonja Berndt, Sonja Berndt, E. Platz, M. Yeager, E. Crawford, A. Hsing, Wen-Yi Huang, R. Hayes (2006)Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.
Cancer research, 66 8
S. Mocellin, F. Marincola, C. Rossi, D. Nitti, M. Lise (2004)The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle.
Cytokine & growth factor reviews, 15 1
Esther Crawley, R. Kay, J. Sillibourne, P. Patel, I. Hutchinson, P. Woo (1999)Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
Arthritis and rheumatism, 42 6
S. Mocellin, F. Marincola, H. Young (2005)Interleukin‐10 and the immune response against cancer: a counterpoint
Journal of Leukocyte Biology, 78
K. Smith, A. Bateman, H. Fussell, W. Howell (2004)Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics, 31 4
D. Turner, D. Williams, D. Sankaran, M. Lazarus, P. Sinnott, I. Hutchinson (1997)An investigation of polymorphism in the interleukin-10 gene promoter.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics, 24 1
Jie Liu, B. Song, Jia‐Lin Wang, Zeng-jun Li, Wanying Li, Zhehai Wang (2011)Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer.
World journal of gastroenterology, 17 10
S. Balasubramanian, I. Azmy, SE Higham, A. Wilson, S. Cross, A. Cox, N. Brown, M. Reed (2006)Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review
BMC Cancer, 6
R. Rad, A. Dossumbekova, B. Neu, R. Lang, S. Bauer, D. Saur, M. Gerhard, C. Prinz (2004)Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection
Jin-guang Yao, Linbo Gao, Yun-guang Liu, J. Li, Guangfu Pang (2008)Genetic variation in interleukin-10 gene and risk of oral cancer.
Clinica chimica acta; international journal of clinical chemistry, 388 1-2
W. Howell, M. Rose-Zerilli (2005)Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis
Familial Cancer, 5
J. Faupel-Badger, L. Kidd, D. Albanes, J. Virtamo, K. Woodson, J. Tangrea (2008)Association of IL-10 polymorphisms with prostate cancer risk and grade of disease
Cancer Causes & Control, 19
N. Mantel, W. Haenszel (1959)Statistical aspects of the analysis of data from retrospective studies of disease.
Journal of the National Cancer Institute, 22 4
N. Uwatoko, T. Tokunaga, H. Hatanaka, H. Osada, T. Kawakami, H. Yamazaki, Y. Abe, H. Kijima, Y. Ueyama, Masato Nakamura (2002)Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma.
International journal of oncology, 20 4
Interleukin-10 (IL-10) plays a key role in immunosuppressive and anti-angiogenic process, suggesting its possible involvement in carcinogenesis. A haplotype formed by polymorphisms at positions -1082 G/A (rs1800896), -819 T/C (rs1800871), and -592 A/C (rs1800872) from the transcriptional start site in the promoter region of the IL-10 gene is a strong determinant for IL-10 production. We systematically reviewed the evidence of association between IL-10 promoter haplotype and cancer risk. Up to November 2011, databases including PubMed, and CNKI (China National Knowledge Infrastructure) were searched to access the relevant genetic association studies. Summary odds ratios and corresponding 95% confidence intervals (CIs) for this haplotype and cancer risk were estimated by using fixed or random-effect models when appropriate. Finally, 12 case–control studies with 2,090 cases and 4,224 controls were available for this study. The summary OR for cancer risk associated with the GCC haplotype was 1.47 (95 % CIs = 1.25–1.72) when compared with ATA haplotype by random effects model. Similarly, significantly increased risks were observed both in Caucasian and in Non Caucasian. Our results suggested that haplotype in IL-10 promoter was involved in the development of cancer.
Familial Cancer – Springer Journals
Published: May 29, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.